Alkem Laboratories Limited has informed the Exchange regarding Intimation for allotment of land for setting up of a greenfield formulation manufacturing facility of the Company in Ujjain, MP.

Capex & Operations View source PDF Explain this filing

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹5360.50

prior close

₹5309.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-3.1%+1.1% vs market

Pharmaceuticals peers, median of 156sector-1.8%-0.1% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Midcap 150 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.9

15m

-1.0

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-3.1+1.1-1.8-0.1

Next day

-1.5-2.5+1.0-0.9-0.6

-3.7-6.3+2.5-4.9+1.1

-1.1-3.9+2.8-3.2+2.0

+1.4-1.7+3.1-1.9+3.3

-1.7-3.8+2.2-4.4+2.7

-2.1-4.2+2.2-3.6+1.5

15d

+4.3+4.3-0.1+7.0-2.7

+4.6+6.2-1.6+6.7-2.1

+2.0+7.8-5.9+9.5-7.5

+0.4+10.7-10.3+13.9-13.6

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has been allotted around 30 acres of land in the DMIC Vikram Udyogpuri Industrial Area, Phase-2, Ujjain, Madhya Pradesh, for setting up a new greenfield formulations manufacturing facility. The Board has approved an investment of up to INR 533 crores, to be made in a phased manner. The allotment letter was received on 18th March 2026 from DMIC Vikram Udyogpuri Limited. The disclosure is being made under SEBI LODR Regulation 30 and will also be uploaded on the company's website.

Likely market impact

This is a meaningful capacity expansion move that signals long-term growth plans, but the phased investment of up to INR 533 crores will be spread over time, so the immediate impact on cash flow or earnings is limited. Shareholders should view this as a positive capacity-building step for future revenue growth.